In a set of newly released presentations, officials from the US Food and Drug Administration (FDA) explain changes to the agency's biomarker qualification program and detail early opportunities for ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on June 21-22, 2010, bringing together key stakeholders, to present promising current and emerging technologies with ...

Every decision in drug development carries weight. The right biomarker insights can make those decisions more confident and data-driven. In this white paper, experts from AstraZeneca, Johnson & ...

Protein biomarkers increasingly play a vital role in advancing health research, driving drug development, and improving clinical outcomes. The close connection between protein biomarkers and human ...

Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

Diagnostic biomarkers are used to detect or confirm the presence of a disease or condition. They can help identify individuals with a particular disease or at high risk of developing the disease.

A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...

Obstacles to free, essential biomarker testing remain as reimbursement negotiations begin, and eligibility criteria require ...